-
RBC Capital Assumes Immunogen Inc. (IMGN) at Outperform
-
ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences
-
Pre-Open Movers 01/31: (CASC) (SFLY) (KNX) Higher; (BLCM) (MGI) (CACC) Lower (more...)
-
ImmunoGen Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Immunogen (IMGN) Prices 14.5M Share Common Offering at $6.50/Sh
-
ImmunoGen Announces Pricing of Public Offering of Common Stock
-
Immunogen (IMGN) Announces 13M Share Common Offering
-
ImmunoGen Announces Proposed Public Offering of Common Stock
-
Pre-Open Movers 07/06: (HSNI) (BGNE) (CYTX) Higher; (EGLT) (TAHO) (AZZ) Lower (more...)
-
UPDATE: RBC Capital Upgrades Immunogen Inc. (IMGN) to Outperform; Sees Another 64% Upside
-
ImmunoGen Announces Webcasts of Presentations at Upcoming Investor Conferences
-
Notable 52-Week Highs and Lows 5/2: (SYY) (MITK) (YNDX) High; (STX) (IMGN) (HAE) Low
-
RBC Capital Downgrades Immunogen Inc. (IMGN) to Sector Perform
-
UPDATE: RBC Capital Cuts Immunogen Inc. (IMGN) to 'Sector Perform' on Concerns About Lead Asset
-
ImmunoGen, Inc. Announces Webcasts of Presentations at Upcoming Investor Conferences
-
Buy Immunogen (IMGN) on Clovis-Related Sell-Off, RBC Capital Says
-
ImmunoGen (IMGN) Reveals Mirvetuximab Phase II Design at Investor Day; RBC Affirms at 'Outperform'
-
Immunogen (IMGN) PT Raised to $20 at RBC Capital Following Meetings
-
Takeda Deal an Endorsement of Immunogen's (IMGN) ADC technology, RBC Capital Says
-
Pre-Open Stock Movers 1/30: (BAMM) (ICPT) (AMZN) Higher; (GENE) (DECK) (ALGN) Lower (more...)
-
Notable Analyst Rating Changes 09/30: (BBRY) (CIT) (CMG) Upgraded; (IP) (ICI) (ARIA) Downgraded
-
Notable Analyst Rating Changes 08/22: (CSIQ) (CNP) (CX) Upgraded; (CLWR) (TSL) (FGP) Downgraded
-
Notable Analyst Rating Changes 05/31: (GS) (NVDA) (TZOO) Upgraded; (GSK) (MDT) (TASR) Downgraded
-
RBC Capital Upgrades Immunogen Inc. (IMGN) to Outperform
-
RBC Capital Downgrades Immunogen (IMGN) to Sector Perform
-
ImmunoGen (IMGN) Says Underwriters Exercised Over-Allotment Option: Total Offer for 10.35M Shares